← Top Holdings

BBIOBRIDGEBIO PHARMA INC

CUSIP: 10806X102

2

Guru Owners

$1.10B

Total Value Held

14.4M

Total Shares

$3.3M
0.01%

📊 Fundamentals

Market Cap$12.7B
Forward P/E3268.0x
EPS (TTM)$-3.78
Revenue (TTM)$502.1M
Profit Margin-144.39%
Beta1.18

52-Week Range

$28.32
$84.94

Current: $65.36

Data from Yahoo Finance · refreshed every 4 hours

📊 Holdings Over Time

How superinvestor ownership has changed across quarters

$0$276.1M$552.1M$828.2M$1.10BQ1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25

Quarter-by-Quarter Activity

Q4 '252 owners · $1.10B
REDUCEDAndreas Halvorsen$1.10B
NEWRay Dalio$3.3M
Q3 '251 owners · $829.9M
REDUCEDAndreas Halvorsen$829.9M
Q2 '251 owners · $801.2M
Q1 '252 owners · $777.6M
Q4 '241 owners · $689.3M

No changes

Q3 '241 owners · $639.6M

No changes

💰 DCF Calculator

DCF model · 10-yr forecast

Estimates depend entirely on your assumptions. Adjust the inputs below to explore scenarios.

⚠️ This company currently has negative free cash flow. The valuation assumes it will improve.
📊 Adjust the assumptions below to calculate an estimated fair value
Projection Period
Revenue Growth Rate
74%analyst est. 73.8%
0%100%
Growth Decay Rate
15%
0% (no decay)50% (fast decay)
Terminal Growth Rate
3.0%
0%5%
FCF Margin
5.0%current: -64.8%
1%50%
Discount Rate (WACC)
8.0%typical: 8% large caps · 10% growth
5%20%

Model: 10-year DCF · 3.0% terminal growth · Based on Yahoo Finance data

🏛️ Congressional Trades

BBIO: Held by 2 superinvestors · 1 congress member trade

$1,001 - $15,0002025-08-08